Usefulness of Procalcitonin in Neonates at Risk for Infection | Zendy

Tanguy MartinDenavit | Zendy; Guillaume Monneret | Zendy; Jean Marc Labaune | Zendy; Christian Isaac | Zendy; Françoise Bienvenu | Zendy; G Putet | Zendy; Jacques Bienvenu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Usefulness of Procalcitonin in Neonates at Risk for Infection

Author(s) -

Tanguy MartinDenavit,

Guillaume Monneret,

Jean Marc Labaune,

Christian Isaac,

Françoise Bienvenu,

G Putet,

Jacques Bienvenu

Publication year - 1999

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1093/clinchem/45.3.440

Subject(s) - procalcitonin , medicine , risk factor , neonatal infection , pediatrics , pregnancy , biology , sepsis , genetics

We are very interested in the report by Sachse et al. (1) on procalcitonin (PCT) variations in the neonatal period. This report confirms and extends previous work on the daily variations of PCT during the first days of life in noninfected newborn infants (2)(3). We agree that PCT could be a useful marker for the presence, course, and prognosis of bacterial infection, particularly in newborns hospitalized with a risk factor for infection (such as an increase in the mother’s body temperature during delivery, premature rupture of membranes, vaginal colonization by group B streptococcus, and other factors). …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research